Average Co-Inventor Count = 2.77
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Paion UK Limited (18 from 21 patents)
18 patents:
1. 12365684 - Short-acting benzodiazepine salts and their polymorphic forms
2. 12201637 - Dosing regimen for sedation with CNS 7056 (Remimazolam)
3. 10961250 - Short-acting benzodiazepine salts and their polymorphic forms
4. 10722522 - Dosing regimen for sedation with CNS 7056 (remimazolam)
5. 10472365 - Short-acting benzodiazepine salts and their polymorphic forms
6. 10342800 - Dosing regimen for sedation with CNS 7056 (Remimazolam)
7. 10195210 - Dosing regimen for sedation with CNS 7056 (Remimazolam)
8. 10052334 - Dosing regimen for sedation with CNS 7056 (remimazolam)
9. 10000464 - Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
10. 9914738 - Short-acting benzodiazepine salts and their polymorphic forms
11. 9827251 - Dosing regimen for sedation with CNS 7056 (remimazolam)
12. 9777007 - Short-acting benzodiazepine salts and their polymorphic forms
13. 9737547 - Dosing regimen for sedation with CNS 7056 (Remimazolam)
14. 9561236 - Dosing regimen for sedation with CNS 7056 (Remimazolam)
15. 9512078 - Process for preparing 3-[(45)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process